Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1981 Sep;34(9):979–981. doi: 10.1136/jcp.34.9.979

Concentration of plasminogen and antiplasmin in plasma and serum

SA Cederholm-Williams 1
PMCID: PMC494210  PMID: 7276224

Abstract

The concentrations of plasminogen and fast-acting antiplasmin were measured in 65 normal plasmas and matched sera. Concentrations were decreased in serum by 38% for plasminogen and 32% for fast-acting antiplasmin. The decrease in plasminogen level was due to both adsorption of plasminogen to fibrin and reaction with antiplasmin.

Full text

PDF
981

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cederholm-Williams S. A., Swain A. The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen)-fibrin complexes. Thromb Res. 1979;16(5-6):705–713. doi: 10.1016/0049-3848(79)90214-7. [DOI] [PubMed] [Google Scholar]
  3. Collen D., Wiman B. Fast-acting plasmin inhibitor in human plasma. Blood. 1978 Apr;51(4):563–569. [PubMed] [Google Scholar]
  4. Hender U., Nilsson I. M., Robertson B. Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh. 1966 Jul 31;16(1):38–50. [PubMed] [Google Scholar]
  5. Ogston D., Ogston C. M., Fullerton H. W. The plasminogen content of thrombi. Thromb Diath Haemorrh. 1966 Jan 31;15(1):220–230. [PubMed] [Google Scholar]
  6. Teger-Nilsson A. C., Friberger P., Gyzander E. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest. 1977 Sep;37(5):403–409. [PubMed] [Google Scholar]
  7. VERMYLEN C., DE VREKER R. A., VERSTRAETE M. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). Clin Chim Acta. 1963 May;8:418–424. doi: 10.1016/0009-8981(63)90080-9. [DOI] [PubMed] [Google Scholar]
  8. Wiman B., Collen D. Molecular mechanism of physiological fibrinolysis. Nature. 1978 Apr 6;272(5653):549–550. doi: 10.1038/272549a0. [DOI] [PubMed] [Google Scholar]
  9. Wiman B., Collen D. On the kinetics of the reaction between human antiplasmin and plasmin. Eur J Biochem. 1978 Mar 15;84(2):573–578. doi: 10.1111/j.1432-1033.1978.tb12200.x. [DOI] [PubMed] [Google Scholar]
  10. Wiman B., Lijnen H. R., Collen D. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen. Biochim Biophys Acta. 1979 Jul 25;579(1):142–154. doi: 10.1016/0005-2795(79)90094-1. [DOI] [PubMed] [Google Scholar]
  11. Wiman B., Wallén P. The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen. Thromb Res. 1977 Feb;10(2):213–222. doi: 10.1016/0049-3848(77)90003-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES